Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism.

Proceedings of the National Academy of Sciences of the United States of America
Meredith W MillerWilliam F DeGrado

Abstract

There is a grave need for safer antiplatelet therapeutics to prevent heart attack and stroke. Agents targeting the interaction of platelets with the diseased vessel wall could impact vascular disease with minimal effects on normal hemostasis. We targeted integrin alpha(2)beta(1), a collagen receptor, because its overexpression is associated with pathological clot formation whereas its absence does not cause severe bleeding. Structure-activity studies led to highly potent and selective small-molecule inhibitors. Responses of integrin alpha(2)beta(1) mutants to these compounds are consistent with a computational model of their mode of inhibition and shed light on the activation mechanism of I-domain-containing integrins. A potent compound was proven efficacious in an animal model of arterial thrombosis, which demonstrates in vivo efficacy for inhibition of this platelet receptor. These results suggest that targeting integrin alpha(2)beta(1) could be a potentially safe, effective approach to long-term therapy for cardiovascular disease.

References

Nov 15, 1990·Thrombosis Research·K D KurzG E Sandusky
Mar 1, 1994·The Journal of Cell Biology·T E O'TooleM H Ginsberg
Feb 1, 1994·Analytical Biochemistry·P BellaviteC Santonastaso
Jun 20, 1997·Journal of Medicinal Chemistry·C B XueR E Olson
Nov 14, 1997·The Journal of Biological Chemistry·J EmsleyR C Liddington
Dec 5, 1998·Journal of Molecular Biology·P Chakrabarti, S Chakrabarti
May 26, 1999·Cardiovascular Research·M D Rekhter
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·C LuT A Springer
Oct 10, 2001·Bioorganic & Medicinal Chemistry Letters·W K HagmannR A Mumford
Jan 5, 2002·Bioorganic & Medicinal Chemistry Letters·Linda L ChangWilliam K Hagmann
Nov 2, 2002·Nature Medicine·Zaverio M Ruggeri
Mar 22, 2003·Blood·Bernhard Nieswandt, Steve P Watson
Sep 3, 2003·Nature Reviews. Drug Discovery·Motomu Shimaoka, Timothy A Springer
Feb 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Wei YangTimothy A Springer
Jun 19, 2004·Blood·Sanford J Shattil, Peter J Newman
Nov 17, 2004·Current Topics in Medicinal Chemistry·Donna M HurynJeffrey D Kennedy
Oct 26, 2005·Thrombosis Research·Michael T TsengUschi M Graham
Feb 16, 2006·Journal of the American Chemical Society·Krista M ThomasNeal J Zondlo
Apr 28, 2006·Protein Science : a Publication of the Protein Society·Ronald T Raines
May 9, 2006·Bioorganic & Medicinal Chemistry Letters·Hang YinWilliam F DeGrado
Jan 5, 2007·Annual Review of Immunology·Bing-Hao LuoTimothy A Springer
Mar 22, 2007·The Journal of Biological Chemistry·Wendy L ConnorsJyrki Heino
Mar 31, 2007·Science·Hang YinWilliam F DeGrado
Oct 6, 2007·Journal of Medicinal Chemistry·Sungwook ChoiWilliam F DeGrado
Nov 15, 2007·Thrombosis and Haemostasis·Marijke J E KuijpersJohan W M Heemskerk

❮ Previous
Next ❯

Citations

Feb 2, 2010·Nature Reviews. Drug Discovery·Alan D Michelson
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Bryan W BergerWilliam F DeGrado
Dec 4, 2009·PloS One·Karen E DrahosDaniel G S Capelluto
Mar 24, 2012·Journal of the American Society of Nephrology : JASN·Corina M BorzaAmbra Pozzi
Oct 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·David T DudleyStephen J Weiss
May 23, 2015·Science Translational Medicine·Nilgun I ReedDean Sheppard
May 4, 2016·Cell and Tissue Research·Kylie P ConroyNeil C Henderson
Sep 20, 2017·Annals of Biomedical Engineering·Sijia ZhangBeth A Winkelstein
Dec 17, 2009·Circulation·Todd L Kiefer, Richard C Becker
May 30, 2019·Toxins·Philip LazaroviciPeter I Lelkes
Feb 18, 2014·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators
Jul 12, 2019·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Sunao TanakaJunji Itou
Apr 19, 2012·Phytotherapy Research : PTR·Chiraphat KloypanNattanan Surapinit
Feb 6, 2020·Proceedings of the National Academy of Sciences of the United States of America·Gaofeng XiongRen Xu
Jun 24, 2015·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·George T El-FerzliHo-Wook Jun
Feb 9, 2021·Frontiers in Immunology·Takeshi Okada, Hidenori Suzuki
May 27, 2021·Expert Opinion on Drug Discovery·Marialucia Gallorini, Simone Carradori
May 7, 2021·The Journal of Clinical Investigation·Sean LiuAparna B Sundaram
Aug 8, 2021·Toxicology and Applied Pharmacology·Emma J HunterRichard W Farndale
Aug 26, 2011·Journal of the American Chemical Society·Jarkko T KoivunenOlli T Pentikäinen
Jun 6, 2014·ACS Medicinal Chemistry Letters·Nis HallandAndreas Lindenschmidt
Jan 31, 2020·Journal of Medicinal Chemistry·Yajun Zheng, Katerina Leftheris
Apr 24, 2010·Molecular Cancer·Maria Simona AguzziAntonio Facchiano
Aug 25, 2009·The American Journal of Pathology·James D San AntonioRenato V Iozzo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.